These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 438338)

  • 1. Corticosteroids inhibit complement-induced granulocyte aggregation. A possible mechanism for their efficacy in shock states.
    Hammerschmidt DE; White JG; Craddock PR; Jacob HS
    J Clin Invest; 1979 Apr; 63(4):798-803. PubMed ID: 438338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro.
    Skubitz KM; Craddock PR; Hammerschmidt DE; August JT
    J Clin Invest; 1981 Jul; 68(1):13-20. PubMed ID: 7251857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methylprednisolone and dexamethasone on polymorphonuclear leukocyte adherence in vivo.
    Bassaris HP; Lianou PE; Mallioris KN; Skoutelis AT; Votta EG; Kyriazopoulou VE; Papavassiliou JT
    Drugs Exp Clin Res; 1987; 13(5):267-71. PubMed ID: 3678036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose corticosteroids and cell-cell interactions.
    Kjellström BT; Risberg B
    Acta Chir Scand Suppl; 1985; 526():37-47. PubMed ID: 3911707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.
    Craddock PR; Hammerschmidt D; White JG; Dalmosso AP; Jacob HS
    J Clin Invest; 1977 Jul; 60(1):260-4. PubMed ID: 874088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-induced vascular leukostasis. Its role in tissue injury.
    Jacob HS
    Arch Pathol Lab Med; 1980 Dec; 104(12):617-20. PubMed ID: 6893656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue damage caused by activated complement and granulocytes in shock lung, post perfusion lung, and after amniotic fluid embolism: ramifications for therapy.
    Jacob HS; Hammerschmidt DH
    Ann Chir Gynaecol Suppl; 1982; 196():3-9. PubMed ID: 6961880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
    Glass F; Lippton H; Kadowitz PJ
    Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
    Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
    J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of high-dose corticosteroids on the pulmonary circulation.
    Vaage J
    Acta Chir Scand Suppl; 1985; 526():73-82. PubMed ID: 3911709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down-regulation.
    Skubitz KM; Hammerschmidt DE
    Blood; 1986 Oct; 68(4):830-6. PubMed ID: 3756350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-mediated leucoembolization: a mechanism of tissue damage during extracorporeal perfusions, myocardial infarction and in shock--a review.
    Jacob HS
    Q J Med; 1983; 52(207):289-96. PubMed ID: 6359225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy among agents inhibiting granulocyte aggregation.
    Hammerschmidt DE; Flynn PJ; Coppo PA; Skubitz KM; Jacob HS
    Inflammation; 1982 Jun; 6(2):169-76. PubMed ID: 7106971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of activated complement and granulocytes in shock states and myocardial infarction.
    Jacob HS
    J Lab Clin Med; 1981 Nov; 98(5):645-53. PubMed ID: 7299236
    [No Abstract]   [Full Text] [Related]  

  • 15. Human endothelial cells inhibit granulocyte aggregation in vitro.
    Zimmerman GA; Klein-Knoeckel D
    J Immunol; 1986 May; 136(10):3839-47. PubMed ID: 3009611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ibuprofen on chemotactic peptide-receptor binding and granulocyte response.
    Skubitz KM; Hammerschmidt DE
    Biochem Pharmacol; 1986 Oct; 35(19):3349-54. PubMed ID: 3021168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)].
    Romero A; Muniain MA; Mata R; Pozuelo F; Pérez JJ; Rodríguez MC; Rodríguez MD
    Rev Esp Fisiol; 1988 Dec; 44(4):407-12. PubMed ID: 3072620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-induced granulocyte aggregation in vivo.
    Hammerschmidt DE; Harris PD; Wayland JH; Craddock PR; Jacob HS
    Am J Pathol; 1981 Feb; 102(2):146-50. PubMed ID: 7468764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of complement and granulocytes in septic shock.
    Jacob HS
    Acta Chir Scand Suppl; 1980; 499():97-106. PubMed ID: 6935903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.